Citadel Advisors
BTTX

Citadel Advisors’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Citadel Advisors’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-216,165
Closed -$42.2K – 15861
2023
Q4 		$42.2K Buy
216,165
+189,999
+726% +$41.3K ﹤0.01% 11967
2023
Q3 		$10.1K Buy
+26,166
New +$17.7K ﹤0.01% 13088
2023
Q2 		– Hold
0
– – – 15632
2023
Q1 		– Hold
0
– – – 15894
2022
Q4 		– Hold
0
– – – 15790
2022
Q3 		– Hold
0
– – – 14164
2022
Q2 		– Sell
-10,535
Closed -$17.6K – 14693
2022
Q1 		$21K Sell
10,535
-2,178
-17% -$7.53K ﹤0.01% 13230
2021
Q4 		$59K Buy
+12,713
New +$104K ﹤0.01% 13158

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.37B AUM 20.71% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $443M AUM 14.48% 1-Year Est. Return